Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
ZCMD
Zhongchao Inc.
CAPPED RATING
Zhongchao Inc. (ZCMD) is rated C- (2.1/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B); its weakest is Growth (F).
Quantitative Factor Evaluation • Updated
Overall Rating
2.1
/ 5.0
C-
Value
B
Factor Score
3.3
/ 5.0
Growth
F
Factor Score
0.3
/ 5.0
Profitability
B
Factor Score
3.4
/ 5.0
Momentum
F
Factor Score
0.7
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
N/A
EV / EBITDA
1.4
Rev Growth YoY
-85.0%
Gross Margin
37.3%
Price Return 3M
-57.5%
Price Return 12M
-99.9%
Catalyst Signal
0.00
Market Cap
$4.0M
TTM Revenue
$6.6M
Price / Sales
0.6
ROE
-42.6%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-15 | B (3.3) | F (0.3) | B (3.4) | F (0.7) | C+ (2.6) | C- (2.1) |
| 2026-11-08 | B (3.4) | F (0.2) | B- (3.0) | F (0.7) | C+ (2.6) | C- (2.0) |
| 2026-11-01 | B (3.3) | D (1.2) | B+ (3.5) | F (0.7) | C+ (2.7) | C (2.3) |
| 2026-10-25 | B (3.3) | D (1.2) | B+ (3.5) | D- (0.7) | C+ (2.6) | C (2.3) |
| 2026-10-18 | B (3.3) | D (1.2) | B+ (3.5) | F (0.6) | C+ (2.6) | C (2.3) |
Page
1
of
4